Neumora Therapeutics
NMRA
NMRA
60 hedge funds and large institutions have $745M invested in Neumora Therapeutics in 2023 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 9 increasing their positions, 8 reducing their positions, and 12 closing their positions.
Holders
60
Holders Change
+22
Holders Change %
+57.89%
% of All Funds
0.88%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.04%
New
34
Increased
9
Reduced
8
Closed
12
Calls
$359K
Puts
$223K
Net Calls
+$136K
Net Calls Change
+$136K
Top Buyers
1 |
IC
1
Iconiq Capital
San Francisco,
California
|
$57.9M |
2 |
2
BlackRock
New York
|
$17.8M |
3 |
JJ
3
Johnson & Johnson
New Brunswick,
New Jersey
|
$31.5M |
4 |
![]()
4
Fidelity Investments
Boston,
Massachusetts
|
$109M |
5 |
5
Goldman Sachs
New York
|
$10.1M |